Pseudomyxoma peritonei differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Nima Nasiri (talk | contribs) |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Pseudomyxoma peritonei}} | {{Pseudomyxoma peritonei}} | ||
{{CMG}}{{AE}}{{Nnasiri}}{{PSD}} | {{CMG}}; {{AE}} {{Nnasiri}} {{PSD}} | ||
==Overview== | ==Overview== | ||
Line 25: | Line 25: | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
| colspan="3" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | | colspan="3" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | ||
! colspan=" | ! colspan="5" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ||
| colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | | colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
Line 33: | Line 33: | ||
|- | |- | ||
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
! colspan=" | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ||
|- | |- | ||
Line 41: | Line 41: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other lab values | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other lab values | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunohistochemistry | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunohistochemistry | ||
! | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT Scan | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Ultrasound | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Ultrasound | ||
|- | |- | ||
Line 61: | Line 61: | ||
* Scalloping of the visceral surfaces differentiates pseudomyxoma from other causes of peritnoitis. | * Scalloping of the visceral surfaces differentiates pseudomyxoma from other causes of peritnoitis. | ||
* Typically does not invade visceral organs or spread by lymphatic or hematogenous routes unlike mucinous carcinomatosis | * Typically does not invade visceral organs or spread by lymphatic or hematogenous routes unlike mucinous carcinomatosis | ||
[[File:Pseudomyxoma-peritonei.jpg|150px|thumb|center|pseudomyxoma peritonei CT [source:Case courtesy of Dr Maxime St-Amant, Radiopaedia.org, rID: 18623]]<br style="clear:left" /> | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* The echoes within pseudomyxoma peritonei are not mobile | * The echoes within pseudomyxoma peritonei are not mobile | ||
Line 93: | Line 91: | ||
* Mesenteric or retroperitoneal lymphadenopathy | * Mesenteric or retroperitoneal lymphadenopathy | ||
* Omental caking, and invasion into parenchymal organs | * Omental caking, and invasion into parenchymal organs | ||
[[File:CT of peritoneal carcinomatosis with peritoneal thickening and omental deposits.jpg|150px|thumb|center|CT of Peritoneal carcinomatosis with peritoneal thickening and omental deposits [https://en.wikipedia.org/wiki/Peritoneal_carcinomatosis source:Subhaschandra Singh, Y. Sobita Devi, Shweta Bhalothia and Veeraraghavan Gunasekaran (2016). "Peritoneal Carcinomatosis: Pictorial Review of Computed Tomography Findings.". International Journal of Advanced Research 4 (7): 735–748. DOI:10.21474/IJAR01/936. ISSN 23205407. CC-BY 4.0]]]<br style="clear:left" /> | |||
| style=" | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Echoes are mobile | * Echoes are mobile | ||
Line 125: | Line 122: | ||
* Hypervascularity with or without | * Hypervascularity with or without | ||
* Hemoperitoneum Variable presence of ascites. | * Hemoperitoneum Variable presence of ascites. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 169: | Line 165: | ||
* Aneurysmal dilatation of the bowel loop with wall thickening may differentiate lymphomatosis from other peritoneal diseases. | * Aneurysmal dilatation of the bowel loop with wall thickening may differentiate lymphomatosis from other peritoneal diseases. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 211: | Line 206: | ||
* low-attenuation lymphadenopathy | * low-attenuation lymphadenopathy | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 248: | Line 242: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Hypoechogenic linear thickening or nodules/masses | * Hypoechogenic linear thickening or nodules/masses | ||
Line 280: | Line 273: | ||
* Small bowel may be matted within loculated fluid collections | * Small bowel may be matted within loculated fluid collections | ||
* Encapsulated small bowel | * Encapsulated small bowel | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Thin echogenic strands can be seen within ascitic fluid; | * Thin echogenic strands can be seen within ascitic fluid; | ||
Line 304: | Line 296: | ||
* SOX2+/OCT4-/NANOG- immunophenotype | * SOX2+/OCT4-/NANOG- immunophenotype | ||
| | | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 330: | Line 321: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Multiple, high-attenuation, linear-branching structures within the mesentery that extend to the peritoneal surfaces | * Multiple, high-attenuation, linear-branching structures within the mesentery that extend to the peritoneal surfaces | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 351: | Line 341: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 369: | Line 358: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 407: | Line 395: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* CT findings are non specific ascites, masses may be seen in peritoneum,mimic neoplasm. | * CT findings are non specific ascites, masses may be seen in peritoneum,mimic neoplasm. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | |
Revision as of 20:25, 21 January 2019
Pseudomyxoma peritonei Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pseudomyxoma peritonei differential diagnosis On the Web |
American Roentgen Ray Society Images of Pseudomyxoma peritonei differential diagnosis |
Risk calculators and risk factors for Pseudomyxoma peritonei differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2] Parminder Dhingra, M.D. [3]
Overview
Pseudomyxoma peritonei must be differentiated from peritoneal carcinomatosis without mucinous ascites, peritoneal sarcomatosis, and peritonitis.
Differential Diagnosis
Pseudomyxoma peritonei must be differentiated from:[1][2]
- Peritoneal carcinomatosis without mucinous ascites
- Peritoneal sarcomatosis
- Tuberclousis peritonitis
- Peritoneal sarcomatosis
- Endometriosis
- Gliomatosis peritonei
- Osseous metaplasia
- Splenosis
- Melanosis
- Inflammatory pseudotumor
- Sclerosis encapsulating peritonitis (Abdominal cocoon)
Differentiating pseudomyxoma peritonei from other diseases
- On the basis of findings on CT scan such as visceral scalloping and histopathology, pseudomyxoma peritonei must be differentiated from other similar rare diseases such as Peritoneal carcinomatosis without muscinous ascites, Tubercluosis peritonitis, Sarcomatosis peritonei.
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Signs | |||||||||
Lab Findings | Imaging | Histopathology | ||||||||
Symptom | Constitutional symptoms | Physical exam | Other lab values | Immunohistochemistry | CT Scan | Ultrasound | ||||
Pseudomyxoma peritonei[3][4] |
|
|
|
|
![]() |
|
|
|
||
Peritoneal carcinomatosis without mucinous ascites[5] |
|
|
|
|
![]() |
|
||||
Peritoneal sarcomatosis |
|
|
|
|
|
|
||||
Lymphomatosis |
|
|
|
|
|
|
|
| ||
Tuberclousis Peritonitis[6][6] |
|
|
|
|
|
|
| |||
Endometriosis[7][8][9] |
|
|
|
|
|
|
|
|
||
Sclerosing encapsulating peritonitis[10][11][12] |
|
|
|
|
|
|
| |||
Gliomatosis Peritonei[13][14] |
|
|
|
|
| |||||
Osseous metaplasia |
|
|
|
|||||||
Splenosis |
|
|
|
|
||||||
Melanosis[15][16][17][18] |
|
|
|
|
| |||||
Inflammatory Pseudotumor[19] |
|
|
|
|
|
|
|
References
- ↑ Harmon RL, Sugarbaker PH (February 2005). "Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer". Int Semin Surg Oncol. 2 (1): 3. doi:10.1186/1477-7800-2-3. PMC 549516. PMID 15701175.
- ↑ Carr NJ, Bibeau F, Bradley RF, Dartigues P, Feakins RM, Geisinger KR, Gui X, Isaac S, Milione M, Misdraji J, Pai RK, Rodriguez-Justo M, Sobin LH, van Velthuysen MF, Yantiss RK (December 2017). "The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei". Histopathology. 71 (6): 847–858. doi:10.1111/his.13324. PMID 28746986.
- ↑ Carranza-Martínez I, Cornejo-López G, Monroy-Argumedo M, Villanueva-Sáenz E (2014). "[Pseudomyxoma peritonei. Two-case-report]". Cir Cir (in Spanish; Castilian). 82 (2): 206–11. PMID 25312322.
- ↑ Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM (December 1995). "Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei"". Am. J. Surg. Pathol. 19 (12): 1390–408. PMID 7503361.
- ↑ Winder T, Lenz HJ (2010). "Mucinous adenocarcinomas with intra-abdominal dissemination: a review of current therapy". Oncologist. 15 (8): 836–44. doi:10.1634/theoncologist.2010-0052. PMC 3228029. PMID 20656916.
- ↑ 6.0 6.1 Kaya M, Kaplan MA, Isikdogan A, Celik Y (2011). "Differentiation of tuberculous peritonitis from peritonitis carcinomatosa without surgical intervention". Saudi J Gastroenterol. 17 (5): 312–7. doi:10.4103/1319-3767.84484. PMC 3178918. PMID 21912057.
- ↑ DiVasta AD, Vitonis AF, Laufer MR, Missmer SA (March 2018). "Spectrum of symptoms in women diagnosed with endometriosis during adolescence vs adulthood". Am. J. Obstet. Gynecol. 218 (3): 324.e1–324.e11. doi:10.1016/j.ajog.2017.12.007. PMID 29247637.
- ↑ Yeaman GR, Collins JE, Lang GA (March 2002). "Autoantibody responses to carbohydrate epitopes in endometriosis". Ann. N. Y. Acad. Sci. 955: 174–82, discussion 199–200, 396–406. PMID 11949946.
- ↑ Kennedy S, Bergqvist A, Chapron C, D'Hooghe T, Dunselman G, Greb R, Hummelshoj L, Prentice A, Saridogan E (October 2005). "ESHRE guideline for the diagnosis and treatment of endometriosis". Hum. Reprod. 20 (10): 2698–704. doi:10.1093/humrep/dei135. PMID 15980014.
- ↑ Suh WN, Lee SK, Chang H, Hwang HJ, Hyung WJ, Park YN, Kim TI (June 2007). "Sclerosing encapsulating peritonitis (abdominal cocoon) after abdominal hysterectomy". Korean J. Intern. Med. 22 (2): 125–9. PMC 2687622. PMID 17616031.
- ↑ Al Ani AH, Al Zayani N, Najmeddine M, Jacob S, Nair S (2014). "Idiopathic sclerosing encapsulating peritonitis (abdominal cocoon) in adult male. A case report". Int J Surg Case Rep. 5 (10): 735–8. doi:10.1016/j.ijscr.2014.07.017. PMC 4189066. PMID 25217877.
- ↑ Sharma D, Nair RP, Dani T, Shetty P (2013). "Abdominal cocoon-A rare cause of intestinal obstruction". Int J Surg Case Rep. 4 (11): 955–7. doi:10.1016/j.ijscr.2013.08.004. PMC 3825929. PMID 24055916.
- ↑ Liang L, Zhang Y, Malpica A, Ramalingam P, Euscher ED, Fuller GN, Liu J (December 2015). "Gliomatosis peritonei: a clinicopathologic and immunohistochemical study of 21 cases". Mod. Pathol. 28 (12): 1613–20. doi:10.1038/modpathol.2015.116. PMC 4682736. PMID 26564007.
- ↑ Lovell MA, Ross GW, Cooper PH (April 1989). "Gliomatosis peritonei associated with a ventriculoperitoneal shunt". Am. J. Clin. Pathol. 91 (4): 485–7. PMID 2648802.
- ↑ Chang ES, Bachul P, Szura M, Szpor J, Okoń K, Walocha JA (September 2015). "Peritoneal "melanosis"". Pol J Pathol. 66 (3): 330–3. PMID 26619112.
- ↑ Gao R, Liu NF, Sheng XG (April 2010). "Malignant ovarian melanoma with extensive pelvic and peritoneal metastasis: a case report and literature review". Chin J Cancer. 29 (4): 460–2. PMID 20346227.
- ↑ Kim SS, Nam JH, Kim SM, Choi YD, Lee JH (March 2010). "Peritoneal melanosis associated with mucinous cystadenoma of the ovary and adenocarcinoma of the colon". Int. J. Gynecol. Pathol. 29 (2): 113–6. doi:10.1097/PGP.0b013e3181bb4182. PMID 20173496.
- ↑ De la Torre Mondragón L, Daza DC, Bustamante AP, Fascinetto GV (December 1997). "Gastric triplication and peritoneal melanosis". J. Pediatr. Surg. 32 (12): 1773–5. PMID 9434025.
- ↑ Maves, C K; Johnson, J F; Bove, K; Malott, R L (1989). "Gastric inflammatory pseudotumor in children". Radiology. 173 (2): 381–383. doi:10.1148/radiology.173.2.2678252. ISSN 0033-8419.